2026进宝看两会丨从开拓走向共建,跨国药械企业深耕中国再提速

中国国际进口博...
Mar 11

在今年的政府工作报告中,生物医药产业迎来了重磅“升格”。从2025年的“新兴产业”升级为2026年的“新兴支柱产业”,两字之差,折射出的却是其产业地位的实质性跨越。“培育壮大生物医药等新兴支柱产业”“强化创新驱动”“实施健康优先发展战略”等一系列政策信号的释放,令不少跨国企业感到振奋。不少企业高管在接受中新网采访时表示,中国市场正从“拼规模、比速度”向“重质量、求效益”深度转型,外企在华的角色定位...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10